BackVerve Therapeutics Overview

Verve Therapeutics Selling, General & Admin

Selling, General & Admin expenses for VERV.

Quarterly SG&A Expenses

$15.15M
↑ 20.93% YoY

As of Mar 31, 2025

Annual SG&A Expenses (TTM)

$57.64M
↑ 19.09% YoY

Trailing 12 months ending Mar 31, 2025

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin